Intercytex approached, but no offer

Intercytex Group, a UK developer of regenerative medicine products, says that, since the announcement in February that it was reviewing strategic  options, the company has held discussions with a number of interested  parties.

Although at an early stage, the company confirms that it has received a  number of approaches which may or may not lead to an offer for  Intercytex or certain business assets. It is the board's intention to  ensure that all interested parties are brought rapidly to the same point  in the process, such that it will be in a position to compare all  potential offers, and to maximize shareholder value.